WHO WE SERVE · VENTURE FUNDS

Diligence without hiring another associate.

Send us the data room. Our analysts run Lensential Venture on it and return what holds up, what does not, the questions for the founder, then the math on your price. The judgment stays with your partners.

Book a call Request a sample

WHAT YOU CAN ASK US

Which of these deals deserve our time?Answered by: Funnel triage and the Screen Are the documents and the numbers real?Answered by: The diligence report, numbers scope Is the product real, and who else could sell it?Answered by: The diligence report, technology scope, and competitive intelligence Who is really in the round?Answered by: The diligence report, people and round scope Can we make money at this price?Answered by: The Exit Brief and the live exit workbook Can we defend this at IC, and what do we tell our LPs?Answered by: The committee decision paper and the investment memo One of our companies is off plan. What can its board still decide?Answered by: Turnaround

WHAT YOU RECEIVE

Every finding, tested against the company's best answer.

FINDINGS REGISTER · THE NUMBERSSPECIMEN

Ref	Finding	Direction	Firmness	The company's best answer	Does it survive?
F-07	USD 240,000 ARR is one USD 18,000 invoice, grossed up and multiplied by twelve	▼ ADVERSE	VERIFIED	"Every early company annualizes a pilot."	Yes, in full. It is the company's arithmetic on the company's documents.
F-06	One customer credit, USD 18,000, in 31 consecutive monthly bank statements	▼ ADVERSE	VERIFIED	"We are pre-commercial."	Yes. The answer concedes it.
F-10	Recomputed runway after the round is 11.8 months, against 18 in the model	▼ ADVERSE	PARTIAL	"The study can be scoped down and hiring slowed."	Partly. Both levers are real, and neither is quantified in the file.
F-15	The bank record is complete, consecutive and free of gaps	▲ FAVORABLE	VERIFIED	None needed.	Yes. Every credit in the company's life is identifiable to a counterparty.

Four of forty findings in the specimen diligence report, which ranks every finding by how well it survives the company's best answer.

Specimen. Thornlark Diagnostics is a fictional company.

See the reports in Lensential Venture

HOW IT WORKS WITH YOU

From the data room to the committee.

On a stated clock.

A screen within 24 hours of the deck. The profile, the competitive position and the exit model within five business days. The diligence series with the memo within ten business days of data-room access, reissued as the founder answers. A principal reads and signs every paper.

Three ways to work with us.

Per paper; a screening retainer of five or ten screens a month, each within 24 hours; or the full series when you decide to pursue a deal. Fees are agreed before work begins; we price from what the same work costs you today.

The deck is where we start.

Every claim that matters gets one of six evidence labels. Anything we could not find is marked MISSING, with the places we looked.

Ready for the committee.

The committee paper puts the cases for and against at their strongest, and names the one event on which they differ.

The market half of the thesis.

Lensential Venture checks the company. Lensential Consult sizes the market it sells into and maps who competes and where the profit sits.

Your own back office, as a build.

We can also build inside your fund, for example a searchable record of every deal you have looked at, or an agent that collects investor updates each quarter.

We do not recommend for or against an investment.

THE SYSTEMS BEHIND IT

Lensential Venture Lensential Consult Lensential Scout PREVIEW Build with us

Send us the last deal you passed on, or the last one you funded.

We screen it free within 24 hours, once per firm. Or ask for a specimen report first.

Book a call